Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Lucid Diagnostics Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 31 | 23 | −8 |
| Shares | 2.46M | 2.30M | −152.5K (−6.2%) |
| Value | $5.55M | $3.52M | −$2.03M (−36.5%) |
New holders (3)
Institutions that held Lucid Diagnostics Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 15,602 | $24.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 7,282 | $11.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 973 | $1.49K | 0.00% |
Sold out (11)
Institutions that held Lucid Diagnostics Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ergoteles LLC | 22,300 | $50.0K |
| Bank of Montreal | 15,524 | $35.0K |
| Bank of America Corp | 1,450 | $3.00K |
| Captrust Financial Advisors | 1,421 | $3.00K |
| JPMorgan Chase & Co | 566 | $1.00K |
| Total Clarity Wealth Management, Inc. | 500 | $1.00K |
| FMR LLC | 182 | $0 |
| New York State Common Retirement Fund | 48 | $0 |
| Credit Suisse AG | 3 | $0 |
| Citigroup Inc | 48 | $0 |
| Ellevest, Inc. | 27 | $0 |